Form 4: Novavax CFO James Patrick Kelly Reports Stock Transactions

EVP, CFO and Treasurer of Novavax, James Patrick Kelly, reports the acquisition and disposal of Novavax common stock on December 31, 2024.

Summary

• On December 31, 2024, James Patrick Kelly, the EVP, CFO, and Treasurer of Novavax Inc., reported transactions involving the company's common stock.
• Kelly acquired 35,000 shares of common stock upon the vesting of Restricted Stock Units (RSUs) at a price of $0.
• Simultaneously, Kelly disposed of 16,906 shares of common stock at a price of $8.04 per share.
• Following these transactions, Kelly directly owns 32,602 shares of Novavax common stock.
• The reported transactions were executed pursuant to the company's Amended and Restated 2015 Stock Incentive Plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities and beneficial ownership of company stock. It allows investors to monitor the actions of key executives and their alignment with the company's performance.

Stakeholder Impact

• The stock transactions of a key executive can influence investor sentiment, although the impact is typically minor unless the transactions are substantial or indicative of a larger trend.

Key Dates